Targeting FGF1-FGFR2 via RORγ Halts Cholangiocarcinoma
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine